Liverpool University is to coordinate a European research project that aims to develop new devices and methods for diagnosing and treating kidney disease.

The University of Liverpool, together with 14 partners, will address current challenges in advancing new therapies that can delay or prevent the progression of kidney injuries to end stage kidney disease.

A key priority will be to develop novel tools and technologies to assess the safety and efficacy of cell-based regenerative medicine therapies for kidney disease.

The RenalToolBox project will receive a total of 4.1 million euros from the European Commission’s Framework Programme Horizon 2020, over the course of four years.

The project places particular emphasis on the training of young researchers, providing support for 15 PhD students in all.

“This exciting research project will provide the appointed students with the required knowledge, skills and state-of-the-art technologies needed to investigate the true potential of renal regenerative medicine therapies,” noted Professor Patricia Murray from the University’s Institute of Translational Medicine.